F. Fakhouri et al., Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta, J AM S NEPH, 12(12), 2001, pp. 2701-2710
Hypertension is frequently associated with the development of renal vascula
r fibrosis. This pathophysiologic process is due to the abnormal formation
of extracellular matrix proteins, mainly collagen type I. In previous studi
es, it has been observed that the pharmacologic blockade of angiotensin II
(Ang II) or endothelin (ET) blunted the development of glomerulo- and nephr
oangiosclerosis in nitric oxide-deficient hypertensive animals by inhibitin
g collagen I gene activation. The purpose of this study was to investigate
whether and how AngII interacts with ET to activate the collagen I gene and
whether transforming growth factor-beta (TGF-beta) could be a player in th
is interaction. Experiments were performed in vivo on transgenic mice harbo
ring the luciferase gene under the control of the collagen I-alpha2 chain p
romoter (procol alpha2[I]). Bolus intravenous administration of AngII or ET
produced a rapid, dose-dependent activation of collagen I gene in aorta an
d renal cortical slices (threefold increase over control at 2 h, P < 0.01).
The AngII-induced effect on procol<alpha>2(I) was completely inhibited by
candesartan (AngII type I receptor antagonist) and substantially blunted by
bosentan (dual ET receptor antagonist) (P < 0.01), whereas the ET-induced
activation of collagen I gene was blocked only by bosentan. In subsequent e
xperiments, TGF-<beta> (also administered intravenously) produced a rapid i
ncrease of procol alpha2(I) in aorta and renal cortical slices (twofold inc
rease over control at 1 h, P < 0.01) that was completely blocked by decorin
(scavenger of the active form of TGF-<beta>). In addition, decorin attenua
ted the activation of collagen I gene produced by An-II (P < 0.01). These d
ata indicate that AngII can activate collagen I gene in aorta and renal cor
tex in vivo by a mechanism(s) requiring participation and/or cooperation of
ET and TGF-<beta>.